How many drugs treat Asthma night-time symptoms?

Drug Landscape tracks 2 marketed treatments for Asthma night-time symptoms (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/asthma-night-time-symptoms.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Asthma night-time symptoms — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Asthma night-time symptoms (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Asthma night-time symptoms, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Theophyllin	Theophyllin	University of Bergen		Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1
Aminophyllin	Aminophyllin	University of Padova		Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Asthma night-time symptoms
University of Bergen · 1 drug in Asthma night-time symptoms
University of Padova · 1 drug in Asthma night-time symptoms

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Asthma night-time symptoms:

Cite this brief

Drug Landscape (2026). Asthma night-time symptoms — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/asthma-night-time-symptoms. Accessed 2026-06-10.

Asthma night-time symptoms full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing